Probiome is a European pharmaceutical company specializing in the development and supply of OTC finished products in the field of gastroenterology.
Our innovative technology platform for microencapsulation of sodium butyrate is a base to create tailor-made products to enrich your portfolio.
Effectiveness of our products are being clinically proven – first clinical trial finished for Divertix
Probiome products are patent pending: ButiRect suppositories application P.442463; ButiSan application P.447248; Divertix application P.446457
